Hi-Acts News & Events

Video: Radiopharmaceuticals are shaping the future of cancer therapy – precise, effective, and gentle. With its strong research, clinical, and industrial ecosystem, Dresden is leading the way and setting an international example of collaboration. Hi-Acts supports the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) in establishing the nukliD network, bringing science, medicine, and industry closer together to make tomorrow’s cancer therapy a reality.

New video out now: Hi-Acts is partnering with Helmholtz-Zentrum Berlin to develop batteries with longer lifespans and higher efficiency. Using synchrotron-based tomography and AI-driven digital twins, researchers can analyze changes inside a battery in real time and accelerate innovation. These breakthroughs are paving the way for sustainable energy solutions of the future.

Research at the HZB beamline – part of the Hi-Acts consortium – provided critical material insights for developing lunar-dust-based solar cells. For more background, tune into the ARD Audiothek Podcast: Listen now, read and enjoy!